Skip to main content

Loading market data...

PBH

Prestige Consumer Healthcare Inc.

NYSE • United states

$47.92

-$1.44

(-2.92%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Prestige Consumer Healthcare Inc. (PBH)

Unavailable

Quotes may be delayed

$2.27B

Market Cap

424,282

Volume

Unavailable

P/E Ratio

Unavailable

Div Yield

Prestige Consumer Healthcare Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 660 WHITE PLAINS RD., TARRYTOWN, NY
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

14 Aug 2026

Prestige Consumer Healthcare Inc. reported A director or senior management change or compensation event

Prestige Consumer Healthcare Inc. filed an 8-K covering a director or senior management change or compensation event.

6 Aug 2026

Prestige Consumer Healthcare Inc. filed Form 10-Q

Prestige Consumer Healthcare Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

6 Aug 2026

Prestige Consumer Healthcare Inc. reported Operating or financial results

Prestige Consumer Healthcare Inc. filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.

15 Jul 2026

Prestige Consumer Healthcare Inc. reported A material agreement

Prestige Consumer Healthcare Inc. filed an 8-K covering a material agreement, a material financing obligation, supporting financial statements or exhibits.

7 Jul 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Prestige Consumer Healthcare Inc..

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$89.13M

Total assets (USD)$4.57B

Total liabilities (USD)$2.65B

Shareholders' equity (USD)$1.92B

Long-term debt (USD)$2.01B

Debt due within a year (USD)$10.45M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$265.71M	$52.52M	$29.18M	$0.61	10-Q · 6 Aug 2026
Q4 2025	$283.44M	$82.49M	$46.70M	$0.97	10-Q · 5 Feb 2026
Q3 2025	$274.11M	$79.67M	$42.21M	$0.86	10-Q · 6 Nov 2025
Q2 2025	$249.53M	$71.76M	$47.47M	$0.95	10-Q · 7 Aug 2025
Q4 2024	$290.32M	$91.96M	$61.03M	$1.22	10-Q · 6 Feb 2025
Q3 2024	$283.79M	$84.34M	$54.38M	$1.09	10-Q · 7 Nov 2024

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $72.00

50.3% upside potential

📈

Strong Buy

Unavailable

👍

Buy

2

⏸️

Hold

0

📉

Sell

0

2 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 22 Oct 2026, 03:50 UTC Targets range 72.00–72.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

4

Aug 2026

ZIER DAWN M.

Director

Grant or award

Unavailable per share

2,981 shares

4

Aug 2026

Kelly John F.

Director

Grant or award

Unavailable per share

2,981 shares

4

Aug 2026

DArecca James

Director

Grant or award

Unavailable per share

2,981 shares

4

Aug 2026

Clark Celeste A.

Director

Grant or award

Unavailable per share

2,981 shares

4

Aug 2026

BYOM JOHN E

Director

Grant or award

Unavailable per share

2,981 shares

11

May 2026

Zerillo Jeffrey

Senior VP Operations

Open-market sale

$52.28 per share

351 shares

7

May 2026

Zerillo Jeffrey

Senior VP Operations

Tax withholding

$54.59 per share

351 shares

7

May 2026

Zerillo Jeffrey

Senior VP Operations

Open-market sale

$54.36 per share

305 shares

2

May 2026

Sacco Christine

CFO & COO

Tax withholding

$55.09 per share

1,091 shares

Top Shareholders

Blackrock, Inc.

7,831,333 shares

5.994% change

6/30/2026

Vanguard Group Inc

5,388,758 shares

-1.893% change

12/31/2025

Ariel Investments, Llc

4,868,711 shares

13.906% change

6/30/2026

Vanguard Portfolio Management Llc

2,825,340 shares

0.767% change

6/30/2026

Dimensional Fund Advisors Lp

2,661,291 shares

-0.43% change

6/30/2026

Fuller & Thaler Asset Management, Inc.

2,331,821 shares

New% change

6/30/2026

Vanguard Capital Management Llc

2,136,944 shares

2.1% change

6/30/2026

State Street Corp

2,116,513 shares

7.384% change

6/30/2026

Brandes Investment Partners, Lp

2,051,060 shares

140.137% change

6/30/2026

Kayne Anderson Rudnick Investment Management Llc

1,872,023 shares

-15.009% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 22 Oct 2026, 03:50 UTC· 3 hours ago

Research coverage and investment tools

Prestige Consumer Healthcare Inc. (PBH) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its last price was US$47.92 on 21 Oct 2026. That is 19% of the way from its 52-week low of US$42.62 to its 52-week high of US$71.07. Its market capitalisation was US$2.27 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$265.71M	$52.52M	$29.18M	$0.61	51.3%	19.8%	$67.09M	10-Q · 6 Aug 2026 (opens in a new tab)
Q4 2025	$283.44M	$82.49M	$46.70M	$0.97	55.5%	29.1%	—	10-Q · 5 Feb 2026 (opens in a new tab)
Q3 2025	$274.11M	$79.67M	$42.21M	$0.86	55.3%	29.1%	—	10-Q · 6 Nov 2025 (opens in a new tab)
Q2 2025	$249.53M	$71.76M	$47.47M	$0.95	56.2%	28.8%	$78.18M	10-Q · 7 Aug 2025 (opens in a new tab)
Q4 2024	$290.32M	$91.96M	$61.03M	$1.22	55.5%	31.7%	—	10-Q · 6 Feb 2025 (opens in a new tab)
Q3 2024	$283.79M	$84.34M	$54.38M	$1.09	55.5%	29.7%	—	10-Q · 7 Nov 2024 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/6/2026	$0.98	$0.89	+10.1%
Mar 2026	5/13/2026	$1.23	$1.39	-11.5%
Dec 2025	2/5/2026	$1.14	$1.16	-1.7%
Sep 2025	11/6/2025	$1.07	$0.97	+10.3%

Cash and equivalents: $89.13M
Total assets: $4.57B
Total liabilities: $2.65B
Shareholders' equity: $1.92B
Long-term debt: $2.01B
Debt due within a year: $10.45M

8-K · 14 Aug 2026 · Management change

Prestige Consumer Healthcare Inc. reported A director or senior management change or compensation event (opens in a new tab)

Prestige Consumer Healthcare Inc. filed an 8-K covering a director or senior management change or compensation event.
10-Q · 6 Aug 2026

Prestige Consumer Healthcare Inc. filed Form 10-Q (opens in a new tab)

Prestige Consumer Healthcare Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 6 Aug 2026

Prestige Consumer Healthcare Inc. reported Operating or financial results (opens in a new tab)

Prestige Consumer Healthcare Inc. filed an 8-K covering operating or financial results, Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 15 Jul 2026 · Material agreement Signed

Prestige Consumer Healthcare Inc. reported A material agreement (opens in a new tab)

Prestige Consumer Healthcare Inc. filed an 8-K covering a material agreement, a material financing obligation, supporting financial statements or exhibits.
SCHEDULE 13G/A · 7 Jul 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Prestige Consumer Healthcare Inc..

Insider	Date	Transaction	Shares	Average price	Filing
ZIER DAWN M. Director	4 Aug 2026	Grant or award (A)	+2,981	—	Form 4 (opens in a new tab)
Kelly John F. Director	4 Aug 2026	Grant or award (A)	+2,981	—	Form 4 (opens in a new tab)
DArecca James Director	4 Aug 2026	Grant or award (A)	+2,981	—	Form 4 (opens in a new tab)
Clark Celeste A. Director	4 Aug 2026	Grant or award (A)	+2,981	—	Form 4 (opens in a new tab)
BYOM JOHN E Director	4 Aug 2026	Grant or award (A)	+2,981	—	Form 4 (opens in a new tab)
Zerillo Jeffrey Senior VP Operations	11 May 2026	Open-market sale (S)	−351	$52.28	Form 4 (opens in a new tab)
Zerillo Jeffrey Senior VP Operations	7 May 2026	Tax withholding (F)	−351	$54.59	Form 4 (opens in a new tab)
Zerillo Jeffrey Senior VP Operations	7 May 2026	Open-market sale (S)	−305	$54.36	Form 4 (opens in a new tab)
Sacco Christine CFO & COO	2 May 2026	Tax withholding (F)	−1,091	$55.09	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	7,831,333	5.994%
Vanguard Group Inc	12/31/2025	5,388,758	-1.893%
Ariel Investments, Llc	6/30/2026	4,868,711	13.906%
Vanguard Portfolio Management Llc	6/30/2026	2,825,340	0.767%
Dimensional Fund Advisors Lp	6/30/2026	2,661,291	-0.43%
Fuller & Thaler Asset Management, Inc.	6/30/2026	2,331,821	New
Vanguard Capital Management Llc	6/30/2026	2,136,944	2.1%
State Street Corp	6/30/2026	2,116,513	7.384%
Brandes Investment Partners, Lp	6/30/2026	2,051,060	140.137%
Kayne Anderson Rudnick Investment Management Llc	6/30/2026	1,872,023	-15.009%

Previous close: 49.36 USD
Day range: 47.50 – 48.84 USD
52-week range: 42.62 – 71.07 USD
Volume: 424,282
Market cap: $2.27B
Average volume: 388,327
EPS (FY 2025, diluted): 3.91 USD
Shares outstanding: 47.37M
Beta (5Y monthly): 0.31

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:00 UTC· 11 hours ago

Average volume, P/E and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:37 UTC· 38 minutes ago

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for PBH yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.